Vital Farms (NASDAQ:VITL) Director Glenda Flanagan Purchases 6,100 Shares
by Jessica Moore · The Cerbat GemVital Farms, Inc. (NASDAQ:VITL – Get Free Report) Director Glenda Flanagan bought 6,100 shares of the business’s stock in a transaction that occurred on Monday, May 18th. The stock was purchased at an average price of $8.33 per share, with a total value of $50,813.00. Following the completion of the purchase, the director directly owned 37,498 shares in the company, valued at $312,358.34. The trade was a 19.43% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Vital Farms Stock Performance
VITL stock traded up $0.26 during mid-day trading on Wednesday, hitting $9.43. 3,439,131 shares of the company were exchanged, compared to its average volume of 2,752,877. The business has a 50 day simple moving average of $12.93 and a 200-day simple moving average of $23.87. The company has a current ratio of 1.77, a quick ratio of 1.00 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $404.08 million, a PE ratio of 9.07 and a beta of 1.20. Vital Farms, Inc. has a 1-year low of $7.95 and a 1-year high of $53.13.
Vital Farms (NASDAQ:VITL – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.12). The company had revenue of $187.16 million for the quarter, compared to analyst estimates of $182.40 million. Vital Farms had a return on equity of 14.47% and a net margin of 6.10%.The company’s revenue was up 15.4% on a year-over-year basis. During the same quarter last year, the business earned $0.37 earnings per share. On average, equities analysts forecast that Vital Farms, Inc. will post -0.45 earnings per share for the current year.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on VITL shares. Mizuho set a $20.00 price target on shares of Vital Farms in a research report on Monday, May 4th. TD Cowen downgraded shares of Vital Farms from a “buy” rating to a “hold” rating and dropped their price target for the company from $25.00 to $16.00 in a research report on Wednesday, April 8th. Wall Street Zen downgraded shares of Vital Farms from a “hold” rating to a “strong sell” rating in a research report on Saturday, May 9th. Morgan Stanley set a $10.00 price target on shares of Vital Farms in a research report on Friday, May 8th. Finally, Needham & Company LLC dropped their price target on shares of Vital Farms from $20.00 to $13.00 and set a “buy” rating for the company in a research report on Monday, May 11th. Five analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $27.33.
Get Our Latest Stock Analysis on Vital Farms
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in VITL. Triumph Capital Management bought a new stake in shares of Vital Farms during the fourth quarter worth $25,000. Quarry LP bought a new stake in shares of Vital Farms during the fourth quarter worth $27,000. Global Retirement Partners LLC grew its stake in shares of Vital Farms by 4,382.6% during the fourth quarter. Global Retirement Partners LLC now owns 1,031 shares of the company’s stock worth $33,000 after buying an additional 1,008 shares during the last quarter. PNC Financial Services Group Inc. grew its stake in shares of Vital Farms by 225.6% during the fourth quarter. PNC Financial Services Group Inc. now owns 1,452 shares of the company’s stock worth $46,000 after buying an additional 1,006 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd bought a new stake in shares of Vital Farms during the third quarter worth $55,000. 98.59% of the stock is owned by institutional investors.
Vital Farms News Roundup
Here are the key news stories impacting Vital Farms this week:
- Positive Sentiment: Several Vital Farms insiders, including directors and an executive, bought shares around $8.00-$8.51, which can signal confidence that the stock is undervalued at current levels. Article: Vital Farms (NASDAQ:VITL) Director Acquires 2,375 Shares
- Neutral Sentiment: Analysts remain cautious overall, with the stock carrying a consensus “Hold” rating and several recent price-target cuts reflecting a weaker near-term outlook. Article: Analysts Offer Insights on Consumer Goods Companies: Archer Daniels Midland (ADM) and Vital Farms (VITL)
- Negative Sentiment: Multiple law firms continue advertising a securities-fraud class action against Vital Farms, with a lead-plaintiff deadline of May 26, keeping litigation risk and investor uncertainty in focus. Article: VITL DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL
About Vital Farms
Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.
Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.
Featured Stories
- Five stocks we like better than Vital Farms
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO